Having established by phenotypic and biochemical analyses that mice harboring two copies of the human LMNA G608G transgene represent a relevant model of classic HGPS, we turned our attention to ways in which this model might be used to identify possible therapeutic interventions to treat children with HGPS. This evidence concerns the gene LMNA and Hutchinson-Gilford progeria syndrome.